B-type Natriuretic Peptide and Risk of Contrast-Induced Acute Kidney Injury in Acute ST-Segment–Elevation Myocardial Infarction
Authors:
- George DangasGDGeorge Dangas
- Kurt HuberKHKurt Huber
- Ke XuKXKe Xu
- Bruce R. BrodieBBBruce R. Brodie
- Bernhard WitzenbichlerBWBernhard Witzenbichler
- D. Christopher MetzgerDMD. Christopher Metzger
- Peter W. RadkePRPeter W. Radke
- Jennifer YuJYJennifer Yu
- Bimmer E. ClaessenBCBimmer E. Claessen
- Philippe GenereuxPGPhilippe Genereux
- Roxana MehranRMRoxana Mehran
- 1 December 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 5 (6) , 813-820
Abstract
Background—: Contrast-induced acute kidney injury (CI-AKI) after percutaneous coronary intervention is associated with adverse short- and long-term outcomes. However, identification of patients at risk for CI-AKI is challenging. Using a large contemporary randomized trial database of patients with ST-segment–elevation myocardial infarction, we therefore sought to examine whether admission B-type natriuretic peptide (BNP) levels predict the development of CI-AKI. Methods and Results—: A total of 979 ST-segment–elevation myocardial infarction patients enrolled in the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial had BNP levels measured in the emergency room prior to primary percutaneous coronary intervention as part of the study protocol. CI-AKI was defined as a relative increase in serum creatinine of ≥25%, or an absolute increase of ≥0.5 mg/dL, occurring within 48 hours after contrast administration. Logistic regression analysis was used to estimate the association of admission BNP with development of CI-AKI. CI-AKI occurred in 131 patients (13.3%). Baseline BNP was a significant univariable correlate of CI-AKI (odds ratio 1.31, 95% confidence interval, 1.14–1.51; P =0.0001). After multivariable adjustment for clinical, laboratory, and angiographic variables, BNP remained a significant independent predictor of CI-AKI (1.29 [1.10, 1.51]; P P P =0.015). Conclusions—: Measurement of serum BNP at hospital admission may help identify patients who are at risk for developing CI-AKI after primary percutaneous coronary intervention in ST-segment–elevation myocardial infarction. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00433966.Keywords
This publication has 35 references indexed in Scilit:
- In-hospital worsening renal function is an independent predictor of one-year mortality in patients with acute myocardial infarctionInternational Journal of Cardiology, 2012
- Effects of Hydration in Contrast-Induced Acute Kidney Injury After Primary AngioplastyCirculation: Cardiovascular Interventions, 2011
- Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II)Circulation, 2011
- Associations Between Acute Kidney Injury and Cardiovascular and Renal Outcomes After Coronary AngiographyCirculation, 2011
- Contrast-Induced Acute Kidney InjuryJACC, 2008
- NGAL is an early predictive biomarker of contrast-induced nephropathy in childrenPediatric Nephrology, 2007
- The Reno-Protective Effect of Hydration With Sodium Bicarbonate Plus N-Acetylcysteine in Patients Undergoing Emergency Percutaneous Coronary InterventionJACC, 2007
- Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarctionJACC, 2004
- Impact of nephropathy after percutaneous coronary intervention and a method for risk stratificationThe American Journal of Cardiology, 2004
- Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary InterventionCirculation, 2002